Stingray Therapeutics Competitors and Similar CompaniesClear all
Stingray Therapeutics's competitors and similar companies include Northwest Biotherapeutics, Merrimack Pharmaceuticals, CytomX Therapeutics and Nektar Therapeutics.
 Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ||
Founding Date | Founding Date 2018 | Founding Date 1998 | Founding Date 2000 | Founding Date 2008 | Founding Date 1990 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Bethesda, US HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US |
Employees | Employees 7 | Employees 1721% increase | Employees 2763% decrease | Employees 15815% increase | Employees 61821% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 349.5 m | Valuation ($) 223.7 m | Valuation ($) 78 m | Valuation ($) 233.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) $55.2m (FY, 2025) |
Net income | Net income N/A | Net income ($60.2m) (FY, 2025) | Net income ($1.2m) (FY, 2023) | Net income ($17.4m) (FY, 2025) | Net income ($164.1m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 135.9m | Total funding raised $ 79.4m | Total funding raised $ 132.4m | Total funding raised $ 45m |
For sources of this data, please see the company profile
View Company Profiles
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View companyMerrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyCytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View company